Treating ALS with Stem Cell Injections: A Clinical Trial

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

https://www.youtube.com/watch?v=p5OoXkNIvHA

Dr. Eva Feldman, a neurologist, researcher and director of the A. Alfred Taubman Biomedical Research Institute at the University of Michigan, is the principal investigator for a landmark clinical trial involving patients with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease. The FDA-approved trial, which is currently in the safety phase, involves injecting hundreds of thousands of stem cells into the spinal cords of patients with ALS. As Dr. Feldman explains in this video, it is hoped the stem cells will provide a healthier environment for the patients’ own nerve cells, preserving function and improving quality of life.

Learn more about ALS: https://bit.ly/ALSNewsToday

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

ALS, amyotrophic lateral sclerosis (ALS), clinical trial, stem cells, treatment

Recent Posts


Recommended reading